Free Newsletter!
Receive free ETF alerts via email every day! Click Here
Regulation SHO took effect January 3, 2005, and provides a new regulatory framework governing short selling of securities. It was designed with the objective of simplifying and modernizing short sale regulation and providing controls where they are most needed. At the conclusion of each settlement day, data is provided on securities in which: 1) there are at least 10,000 shares in aggregate failed deliveries for the security for five consecutive settlement days, and 2) these failures constitute at least 0.5% of the issuer's total shares outstanding. Regulation SHO mandates that, if a clearing agent has had a fail-to-deliver position for 13 consecutive settlement days, that clearing agent, and the broker/dealer it clears for, must purchase securities to close out its fail to deliver position.
Athersys Inc. (NASDAQ: ATHX | Quote | Chart | News | PowerRating) a biopharmaceutical company, engages in the discovery and development of therapeutic product candidates in multiple disease areas in the United States. Its product pipeline includes ATHX-105, a Phase I clinical trial product for the treatment of obesity. The company also develops orally active pharmaceutical products for the treatment of central nervous system disorders that include sleep disorders, such as narcolepsy or excessive daytime sleepiness; and other potential indications comprising attention deficit hyperactivity disorder and other cognitive disorders. In addition, Athersys, through its product co-development collaboration with Angiotech Pharmaceuticals, Inc., develops MultiStem for the treatment of damage caused by myocardial infarction and peripheral vascular disease, as well as for hematopoietic stem cell transplant support, ischemic stroke, and other disease indications. The company was founded in 1995 and is based in Cleveland, Ohio. With 18.93 million shares outstanding and 1,200 shares declared short as of May 2008, the failure to deliver in shares of ATHX has not been resolved and a buy-in is imminent.
Avant Immunotherapeutics Inc. (NASDAQ: AVAN | Quote | Chart | News | PowerRating) a biopharmaceutical company, engages in the discovery, development, and commercialization of vaccines and targeted immunotherapeutics for the treatment of cancer, infectious, and inflammatory diseases. The company focuses on the use of tumor-specific targets and human monoclonal antibodies to precisely deliver therapeutic agents through targeted immunization approach. It also offers bacterial vector delivery technologies with manufacturing and preservation processes that offer the potential for a new generation of infectious disease vaccines. The company's products include Rotarix for the prevention of rotavirus infection; and two human food safety vaccines for reducing salmonella infection in chickens and eggs. Its product pipeline also consists of products in various stages of development, including CDX-110, which is undergoing evaluation in a Phase 2/3 clinical trial for the treatment of glioblastoma multiforme, an aggressive form of brain cancer; CDX-1307, a product based on its proprietary APC Targeting Technology, which is in two Phase 1 clinical trials for patients with advanced pancreatic, bladder, breast, and colon cancer; a TP10, a complement inhibitor for transplantation and other indications; and three candidates based on its oral, rapidly-protecting, single-dose, and temperature-stable vaccine technology, such as combination vaccines for travelers, the military, and health needs. AVANT Immunotherapeutics has collaborative agreements with GlaxoSmithKline for the development and commercialization of oral rotavirus vaccine; Pfizer, Inc. for discovery and development of vaccines to protect animals, and to develop CDX-110; and Select Vaccines Limited for the development of viral vaccines. The company was founded in 1983 and is headquartered in Needham, Massachusetts. With 14.93 million shares outstanding and 229,200 shares declared short as of May 2008, the failure to deliver in shares of AVAN has not been resolved and a buy-in is imminent. According to quarterly data provided by the SEC, there were still 12,728 shares of AVAN that were failing-to-deliver as of August 10, 2007.
Habersham Bancorp (NASDAQ: HABC | Quote | Chart | News | PowerRating) operates as the holding company for Habersham Bank that offers commercial banking services in Habersham, White, Cherokee, Warren, Gwinnett, Stephens, Forsyth, and Hall Counties, Georgia. It provides various deposit products, including checking and savings accounts, various types of time deposits, money market, and NOW account, as well as individual retirement accounts. The company's loan portfolio comprises commercial, financial, and agricultural loans; real estate loans; and installment loans to individuals. It also offers trust services, including trust administration, asset management services, estate and will probate and administration, and other services in the area of personal trusts. In addition, Habersham Bancorp provides property, casualty, and life insurance products, as well as offers safe deposit facilities. As of December 31, 2007, it operated 12 branch offices in Georgia. The company was founded in 1904 and is based in Cornelia, Georgia. With 2.82 million shares outstanding and 71,200 shares declared short as of May 2008, the failure to deliver in shares of HABC has not been resolved and a buy-in is imminent.
King Resources Inc. (OTC: KING | Quote | Chart | News | PowerRating) formerly ARXA International Energy, Inc., operates as an independent oil and gas company engaged in the acquisition, exploration, development, and production of oil and gas properties in the United States. As of October 31, 2000 King does not operate any oil and gas properties. With 152.69 million shares outstanding and 34,100 shares declared short as of May 2008, the failure to deliver in shares of KING has not been resolved and a buy-in is imminent. According to quarterly data provided by the SEC, there were still 610,000 shares of KING that were failing-to-deliver as of September 28, 2007.
Calpine Corporation (OTC: CPNCW) engages in the generation and sale of electricity and related products and services to wholesale and industrial customers in North America. It offers electricity generated from natural gas-fired combustion and renewable geothermal facilities. The company also operates power plants, geothermal steam fields, wells and well pumps, and gas pipelines. It sells its thermal energy produced by the gas-fired power cogeneration facilities primarily to industrial users. The company markets electricity produced from its generating facilities to utilities and other third party purchasers. As of December 31, 2007, it owned or leased a portfolio of 60 natural gas-fired power plants and 17 geothermal power plants with approximately 24,000 megawatts of generating capacity. The company was founded in 1984 and is based in San Jose, California and has an additional office in Houston, Texas. With 2.86 million shares declared short as of May 2008, the failure to deliver in shares of CPNCW has not been resolved and a buy-in is imminent.
Wavefront Energy and Environmental Services, Inc. (OTC: WEESF | Quote | Chart | News | PowerRating) engages in the development and commercialization of technologies for fluid flow optimization processes in the environmental and energy sectors in Canada and the United States. It offers the Powerwave process, which is an injection technology that improves the flow of fluids in geological materials, including sedimentary soils and fractured rock; and Primawave process, a method of environmental groundwater remediation of contaminated sites. These technologies enhance oil recovery, oil well stimulation, oilfield disposal methodologies, and optimization of groundwater remediation. The company is headquartered in Edmonton, Canada with additional offices in Cambridge, Canada; and Houston, the United States. With 48.6 million shares outstanding and an undisclosed short position, the failure to deliver in shares of WEESF has not been resolved and a buy-in is possible. According to quarterly data provided by the SEC, there were still 217,677 shares of WEESF that were failing-to-deliver as of August 30, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,000,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
